Laverock Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Apex Bldg, 6 St. Pancras Way, London, Gr...Website
www.laverocktx.comRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Laverock Therapeutics
Laverock Therapeutics is pioneering programmable gene silencing with its proprietary GEiGS® platform, enabling precise and durable control of gene expression. Their technology is designed to power next-generation cell and gene therapies in oncology, regenerative medicine, and rare genetic diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laverock Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Laverock Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Laverock Therapeutics has new funding data
Product Launch: Get notified when Laverock Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check out if Laverock Therapeutics is spiking on competitors!
Click to see if Laverock Therapeutics had a recent Job posting/layoffs
Laverock Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Laverock Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Laverock Therapeutics
Recommended Actions
Find VP level buyers at Laverock Therapeutics
Find 3 more new buyers
Compare Similar Companies to Laverock Therapeutics
Compare insights from companies similar to Laverock Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Laverock Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Laverock Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Laverock Therapeutics.
Laverock Therapeutics financials insights
Gather financial insights about Laverock Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$14.1M
2025
Seed
$27.4M
Laverock Therapeutics Tech Stack
A closer look at the technologies used by Laverock Therapeutics
Most Recent Scoops
Funding
Funding
Open Position
Open Position
Open Position
Open Position
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Laverock Therapeutics
Sign Up For FreeTo access detailed company insights
Laverock Therapeutics is pioneering programmable gene silencing with its proprietary GEiGS® platform, enabling precise and durable control of gene expression. Their technology is designed to power next-generation cell and gene therapies in oncology, regenerative medicine, and rare genetic diseases.... Read More
